Losing weight means losing some muscle along with fat. What the research says about how much, why it matters, and the two levers that protect lean mass: protein intake and resistance training.
The scale cannot tell the difference between a pound of fat and a pound of muscle. When weight falls quickly, as it often does on a GLP-1 medication, some of what disappears is lean tissue. This happens with any method of weight loss, including dieting and surgery, but it has become a central conversation because the newer medications produce larger and faster losses than most diets. This article reviews the research and the two evidence-based ways to limit muscle loss. It is educational, not individual advice.
A 2024 viewpoint in JAMA by researchers from the National Institute of Diabetes and Digestive and Kidney Diseases and Washington University reviewed this question for GLP-1-based medications. Their core points: a portion of weight lost with these medications is fat-free mass, as it is with diet-induced weight loss; people with obesity typically carry more muscle to begin with, so absolute muscle mass afterward often remains in a normal range; and the clinical relevance depends on who is losing the weight. For an older adult already near the threshold of frailty, it matters more.
The Recommended Dietary Allowance is 0.8 grams per kilogram of body weight per day, designed to prevent deficiency under ordinary conditions. During active weight loss, published guidance moves higher. The 2015 review by Leidy and colleagues found that higher-protein diets during energy restriction produced greater fat loss and better preservation of lean mass. The 2024 guidance for antiobesity medications by Almandoz and colleagues points to roughly 1.2 to 1.6 grams per kilogram per day for most adults, adjusted for kidney disease, older age and very high body weight.
People with chronic kidney disease may be advised to limit protein, which is why targets should be individualized.
In a 2017 New England Journal of Medicine trial by Villareal and colleagues, older adults with obesity followed a weight-management program plus aerobic training, resistance training, both, or neither. All exercise groups lost about 9 percent of body weight, but lean mass fell by about 5 percent in the aerobic-only group compared with 3 percent in the combined group and 2 percent in the resistance-only group. Physical performance improved most in the combination group.
The Physical Activity Guidelines for Americans recommend muscle-strengthening activities involving all major muscle groups on two or more days per week, in addition to aerobic activity. For someone new to lifting, two full-body sessions a week is a reasonable start.
Body-fat bathroom scales are imprecise, and hydration changes can swing the readings. More useful signals include whether your lifts are holding steady, whether everyday tasks feel easier, waist circumference, and grip strength.
Protein targets and exercise plans should account for your kidney function, joint health, cardiovascular history and other medications. A licensed provider can help set realistic targets. This article is educational and does not determine eligibility for any treatment.
This article is educational and does not diagnose conditions, establish eligibility for any medication, or replace care from a licensed provider. Compounded medications are not FDA-approved.
Both are weekly injectables that act on gut hormone receptors, but they are not the same molecule. Here is how they differ in mechanism, trial results, side effects and regulatory status.
Read articleGLP-1 medications copy a hormone your gut already makes. Here is what that hormone does, how the medications change appetite and digestion, and which products are FDA-approved versus compounded.
Read articleNausea, constipation, fatigue and other frequent side effects of GLP-1 medications, what the trial data say about how common they are, and practical strategies people use with their provider's guidance.
Read article